Last additions - Mtehylenetetrahydrofolate reductase c677T homozygous CRVO pregnant woman (MTHFR) 38 year old woman with only one eye. Her left eye was removed for retinoblastoma when she was a child. She has vision loss in the right eye for 2 weeks. She is 12 weeks pregnant and has had trouble with her past pregnancy and a miscarriage. Vision is 20/50. There is macular edema and a CRVO. She did well and recovered 20/16 vision in about a month with an ozurdex injection. Testing showed that she was homozygous for MTHFR c677t. Homocyteine results were not available.
|
Mtehylenetetrahydrofolate reductase c677T homozygous CRVO pregnant woman (MTHFR)478 viewsVision improved from 20/50 to 20/16 in one month following ozurdex injections. 38 year old woman with only one eye. The left eye was removed as a child for retinoblastoma.Oct 05, 2015
|
|
Mtehylenetetrahydrofolate reductase c677T homozygous CRVO pregnant woman (MTHFR)504 viewsVision improved from 20/50 to 20/16 in one month following ozurdex injections. 38 year old woman with only one eye. The left eye was removed as a child for retinoblastoma.Oct 05, 2015
|
|
Mtehylenetetrahydrofolate reductase c677T homozygous CRVO pregnant woman (MTHFR)427 viewsVision improved from 20/50 to 20/16 in one month following ozurdex injections. 38 year old woman with only one eye. The left eye was removed as a child for retinoblastoma.Oct 05, 2015
|
|
Mtehylenetetrahydrofolate reductase c677T homozygous CRVO pregnant woman (MTHFR)454 viewsVision improved from 20/50 to 20/16 in one month following ozurdex injections. 38 year old woman with only one eye. The left eye was removed as a child for retinoblastoma.Oct 05, 2015
|
|
Mtehylenetetrahydrofolate reductase c677T homozygous CRVO pregnant woman (MTHFR)445 viewsVision improved from 20/50 to 20/16 in one month following ozurdex injections. 38 year old woman with only one eye. The left eye was removed as a child for retinoblastoma.Oct 05, 2015
|
|
Mtehylenetetrahydrofolate reductase c677T homozygous CRVO pregnant woman (MTHFR)442 viewsVision improved from 20/50 to 20/16 in one month following ozurdex injections. 38 year old woman with only one eye. The left eye was removed as a child for retinoblastoma.Oct 05, 2015
|
|
Mtehylenetetrahydrofolate reductase c677T homozygous CRVO pregnant woman (MTHFR)427 viewsVision improved from 20/50 to 20/16 in one month following ozurdex injections. 38 year old woman with only one eye. The left eye was removed as a child for retinoblastoma.Oct 05, 2015
|
|
Mtehylenetetrahydrofolate reductase c677T homozygous CRVO pregnant woman (MTHFR)440 viewsVision improved from 20/50 to 20/16 in one month following ozurdex injections. 38 year old woman with only one eye. The left eye was removed as a child for retinoblastoma.Oct 05, 2015
|
|
Mtehylenetetrahydrofolate reductase c677T homozygous CRVO pregnant woman (MTHFR)470 viewsVision improved from 20/50 to 20/16 in one month following ozurdex injections. 38 year old woman with only one eye. The left eye was removed as a child for retinoblastoma.Oct 05, 2015
|
|
Mtehylenetetrahydrofolate reductase c677T homozygous CRVO pregnant woman (MTHFR)454 viewsVision improved from 20/50 to 20/16 in one month following ozurdex injections. 38 year old woman with only one eye. The left eye was removed as a child for retinoblastoma.Oct 05, 2015
|
|
Mtehylenetetrahydrofolate reductase c677T homozygous CRVO pregnant woman (MTHFR)493 viewsVision improved from 20/50 to 20/16 in one month following ozurdex injections. 38 year old woman with only one eye. The left eye was removed as a child for retinoblastoma.Oct 05, 2015
|
|
|
|
|
38 year old woman with only one eye. Her left eye was removed for retinoblastoma when she was a child. She has vision loss in the right eye for 2 weeks. She is 12 weeks pregnant and has had trouble with her past pregnancy and a miscarriage. Vision is 20/50. There is macular edema and a CRVO. She did well and recovered 20/16 vision in about a month with an ozurdex injection. Testing showed that she was homozygous for MTHFR c677t. Homocyteine results were not available.
